- Report
- August 2023
- 270 Pages
Global
From €2353EUR$2,450USD£2,026GBP
Uterine cancer is a type of cancer that affects the uterus, a female reproductive organ. It is the most common type of gynecologic cancer in the United States. Uterine cancer is typically diagnosed in women over the age of 50, and is often caused by a combination of genetic and environmental factors. Symptoms of uterine cancer include abnormal vaginal bleeding, pelvic pain, and pain during intercourse. Treatment options for uterine cancer include surgery, radiation therapy, chemotherapy, and hormone therapy.
The oncology market for uterine cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new drugs and treatments to improve outcomes for patients. Additionally, medical device companies are developing new technologies to improve diagnosis and treatment of uterine cancer.
Some companies in the uterine cancer market include AstraZeneca, Pfizer, Merck, Novartis, and Roche. Show Less Read more